DiaMedica Therapeutics (DMAC) Retained Earnings (2017 - 2026)
DiaMedica Therapeutics (DMAC) reported Retained Earnings of -$182.8 million for Q1 2026, down 3656300.0% on a YoY basis from N/an in Q1 2025, and down 365720.0% quarter-over-quarter from $50000.0 in Q4 2025.
DiaMedica Therapeutics (DMAC) Retained Earnings (2017 - 2026) Analysis & Trends
DiaMedica Therapeutics has reported Retained Earnings for 10 years, with the latest figure at -$182.8 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 3656300.0% year-over-year to -$182.8 million; the trailing twelve-month figure through Mar 2026 stood at -$182.8 million (down 3656300.0% YoY), and the FY2025 full-year result was $50000.0, up 100.04% from the prior year.
- Retained Earnings for Q1 2026 stood at -$182.8 million, down from $50000.0 in the prior quarter.
- The five-year high for Retained Earnings was $50000.0 in Q3 2025, with the low at -$182.8 million in Q1 2026.
- Historically, Retained Earnings has averaged -$86.0 million across 5 years, with a median of -$101.4 million in 2023.
- Annual changes were most pronounced in 2025 — Retained Earnings jumped 100.04% — and 2026, when it sank 3656300.0%.
- DiaMedica Therapeutics' Retained Earnings stood at -$96.2 million in 2022, then declined by 20.15% to -$115.6 million in 2023, then fell by 21.15% to -$140.0 million in 2024, then jumped by 100.04% to $50000.0 in 2025, then sank by 365720.0% to -$182.8 million in 2026.
- The last three Retained Earnings figures came in at -$182.8 million (Q1 2026), $50000.0 (Q4 2025), and $50000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | -153.89 Mn |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | -211.85 Mn |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -279.00 Mn |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | 130.89 Mn |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1.88 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 14.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -838.07 Mn |
| 10 | DiaMedica Therapeutics | 285.11 Mn | 233.77 Mn | - | -182.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182.81 Mn |
| Dec 31, 2025 | 50,000.00 |
| Sep 30, 2025 | 50,000.00 |
| Jun 30, 2025 | -155.40 Mn |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | -140.00 Mn |
| Sep 30, 2024 | -132.10 Mn |
| Jun 30, 2024 | -125.80 Mn |
| Mar 31, 2024 | -120.70 Mn |
| Dec 31, 2023 | -115.56 Mn |
| Sep 30, 2023 | -110.40 Mn |
| Jun 30, 2023 | -63,000.00 |
| Mar 31, 2023 | -101.45 Mn |
| Dec 31, 2022 | -96.18 Mn |
| Sep 30, 2022 | -92.43 Mn |
| Jun 30, 2022 | -89.40 Mn |
| Mar 31, 2022 | -107,000.00 |
| Dec 31, 2021 | -82.50 Mn |
| Sep 30, 2021 | -79.26 Mn |
| Jun 30, 2021 | -3,000.00 |